CareDx Gross Margin 2013-2025 | CDNA
Current and historical gross margin for CareDx (CDNA) over the last 10 years. The current gross profit margin for CareDx as of March 31, 2025 is %.
| CareDx Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2025-03-31 | $0.35B | $0.23B | 67.15% |
| 2024-12-31 | $0.33B | $0.22B | 66.77% |
| 2024-09-30 | $0.31B | $0.21B | 65.50% |
| 2024-06-30 | $0.30B | $0.19B | 64.98% |
| 2024-03-31 | $0.28B | $0.17B | 62.91% |
| 2023-12-31 | $0.28B | $0.18B | 63.57% |
| 2023-09-30 | $0.30B | $0.19B | 64.53% |
| 2023-06-30 | $0.31B | $0.20B | 64.61% |
| 2023-03-31 | $0.32B | $0.21B | 65.20% |
| 2022-12-31 | $0.32B | $0.21B | 65.42% |
| 2022-09-30 | $0.32B | $0.21B | 65.72% |
| 2022-06-30 | $0.32B | $0.21B | 66.35% |
| 2022-03-31 | $0.31B | $0.21B | 66.88% |
| 2021-12-31 | $0.30B | $0.20B | 67.23% |
| 2021-09-30 | $0.28B | $0.19B | 67.75% |
| 2021-06-30 | $0.25B | $0.17B | 68.38% |
| 2021-03-31 | $0.22B | $0.15B | 67.87% |
| 2020-12-31 | $0.19B | $0.13B | 67.71% |
| 2020-09-30 | $0.17B | $0.11B | 66.86% |
| 2020-06-30 | $0.15B | $0.10B | 65.33% |
| 2020-03-31 | $0.14B | $0.09B | 65.47% |
| 2019-12-31 | $0.13B | $0.08B | 63.78% |
| 2019-09-30 | $0.12B | $0.07B | 61.74% |
| 2019-06-30 | $0.10B | $0.06B | 59.80% |
| 2019-03-31 | $0.09B | $0.05B | 58.43% |
| 2018-12-31 | $0.08B | $0.04B | 57.14% |
| 2018-09-30 | $0.07B | $0.04B | 57.58% |
| 2018-06-30 | $0.06B | $0.03B | 57.89% |
| 2018-03-31 | $0.05B | $0.03B | 56.86% |
| 2017-12-31 | $0.05B | $0.03B | 55.10% |
| 2017-09-30 | $0.05B | $0.02B | 51.06% |
| 2017-06-30 | $0.05B | $0.02B | 51.06% |
| 2017-03-31 | $0.05B | $0.02B | 47.83% |
| 2016-12-31 | $0.04B | $0.02B | 48.78% |
| 2016-09-30 | $0.04B | $0.02B | 54.05% |
| 2016-06-30 | $0.03B | $0.02B | 56.25% |
| 2016-03-31 | $0.03B | $0.02B | 64.29% |
| 2015-12-31 | $0.03B | $0.02B | 67.86% |
| 2015-09-30 | $0.03B | $0.02B | 72.41% |
| 2015-06-30 | $0.03B | $0.02B | 72.41% |
| 2015-03-31 | $0.03B | $0.02B | 68.97% |
| 2014-12-31 | $0.03B | $0.02B | 67.86% |
| 2014-09-30 | $0.03B | $0.02B | 65.38% |
| 2014-06-30 | $0.03B | $0.02B | 60.00% |
| 2014-03-31 | $0.02B | $0.01B | 60.87% |
| 2013-12-31 | $0.02B | $0.01B | 59.09% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $1.129B | $0.334B |
| CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.821B | 26.97 |
| CVS Health (CVS) | United States | $84.326B | 10.48 |
| Elevance Health (ELV) | United States | $78.255B | 10.10 |
| Cencora (COR) | United States | $58.178B | 20.24 |
| DiDi Global (DIDIY) | China | $23.485B | 24.95 |
| Natera (NTRA) | United States | $22.086B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.684B | 17.59 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.804B | 0.00 |
| Solventum (SOLV) | United States | $12.836B | 13.59 |
| CochLear (CHEOY) | Australia | $12.824B | 0.00 |
| ICON (ICLR) | Ireland | $12.156B | 11.30 |
| Revvity (RVTY) | United States | $11.802B | 20.31 |
| Viatris (VTRS) | United States | $10.833B | 3.72 |
| Avantor (AVTR) | United States | $9.247B | 13.44 |
| Medpace Holdings (MEDP) | United States | $9.225B | 24.50 |
| HealthEquity (HQY) | United States | $8.646B | 37.87 |
| Sonic Healthcare (SKHHY) | Australia | $8.518B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.808B | 15.30 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.930B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.971B | 29.27 |
| BrightSpring Health Services (BTSG) | United States | $3.760B | 34.50 |
| Sotera Health (SHC) | United States | $3.296B | 18.73 |
| Surgery Partners (SGRY) | United States | $2.870B | 37.32 |
| Alignment Healthcare (ALHC) | United States | $2.750B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.622B | 100.97 |
| Concentras Parent (CON) | United States | $2.619B | 15.13 |
| Organon (OGN) | United States | $2.576B | 2.74 |
| Progyny (PGNY) | United States | $2.038B | 44.87 |
| Ardent Health (ARDT) | United States | $1.981B | 8.45 |
| PACS (PACS) | United States | $1.957B | 0.00 |
| Premier (PINC) | United States | $1.778B | 13.49 |
| GoodRx Holdings (GDRX) | United States | $1.739B | 34.79 |
| Teladoc Health (TDOC) | United States | $1.553B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.303B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.165B | 8.86 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.948B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.846B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.833B | 7.80 |
| Nutex Health (NUTX) | United States | $0.643B | 9.73 |
| Embecta (EMBC) | United States | $0.619B | 4.17 |
| InnovAge Holding (INNV) | United States | $0.571B | 0.00 |
| SBC Medicals (SBC) | United States | $0.546B | 0.00 |
| LifeMD (LFMD) | United States | $0.535B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.484B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.471B | 10.62 |
| So-Young (SY) | China | $0.440B | 0.00 |
| Omada Health (OMDA) | $0.434B | 0.00 | |
| Enhabit (EHAB) | United States | $0.368B | 30.29 |
| Performant Healthcare (PHLT) | United States | $0.335B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.330B | 0.00 |
| Beauty Health (SKIN) | United States | $0.263B | 0.00 |
| Oncology Institute (TOI) | United States | $0.216B | 0.00 |
| DocGo (DCGO) | United States | $0.159B | 26.00 |
| Pheton Holdings (PTHL) | China | $0.132B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.100B | 0.00 |
| KindlyMD (NAKA) | United States | $0.074B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.067B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| ModivCare (MODV) | United States | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.046B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.024B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |